サマリー

世界のラジオイムノアッセイ市場は、2023年から2030年の予測期間に4.1%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。
市場セグメンテーションを行います：
ラジオイムノアッセイの世界市場、製品タイプ別（ラジオイムノアッセイ試薬・キット、ラジオイムノアッセイアナライザー）、用途別（科学研究、臨床診断）、エンドユーザー別（病院、臨床診断研究所、学術・研究機関、製薬・バイオ医薬品業界、受託研究機関、その他）、流通チャネル別（直接入札、オンライン販売、第三者流通、その他）、国（U.S、カナダ、メキシコ、ドイツ、フランス、英国、イタリア、スペイン、ロシア、トルコ、ベルギー、デンマーク、オランダ、スイス、スウェーデン、ポーランド、ノルウェー、フィンランド、その他の欧州、中国、日本、インド、韓国、オーストラリア、インドネシア、フィリピン、タイ、マレーシア、シンガポールその他のアジア太平洋、ブラジル、アルゼンチン、その他の南米、南アフリカ、サウジアラビア、UAE、エジプト、イスラエル、その他の中東・アフリカ） 産業動向と2030年までの予測

世界のラジオイムノアッセイ市場の成長に寄与する主な要因として、以下のものが挙げられます：
- 高スループットと自動化された手順による、エラーのない正確な結果に対する需要の増加
- 技術的進歩の高まり
- 市場関係者の戦略的な取り組み
- 医学における研究開発の意義が高まる

市場のプレーヤー：

世界のラジオイムノアッセイ市場の主要な市場関係者は以下の通りです：

- パーキンエルマー株式会社
- エムピーバイオメディカルズ
- テカントレーディングAG
- メルクKGaA
- 株式会社イムノバイオロジーラボラトリーズ
- EUROIMMUN Medizinische Labordiagnostika AG（ユーロイムン メディジニッシェ ラボルダグノスティカ アグ
- カミヤバイオメディカル株式会社
- ベックマン・コールター社
- デメディテック・ダイアグノスティックス社
- マイバイオソース・ドットコム
- DiaSource（ダイアソース
- ベルソルトテクノロジーズGmbH & Co.KG
- ハイデックスOy.
- アイソトープス研究所
- アブカム・ピーエルシー

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 66
1.1 OBJECTIVES OF THE STUDY 66
1.2 MARKET DEFINITION 66
1.3 OVERVIEW OF GLOBAL RADIOIMMUNOASSAY MARKET 66
1.4 LIMITATIONS 68
1.5 MARKETS COVERED 68
2 MARKET SEGMENTATION 72
2.1 MARKETS COVERED 72
2.2 GEOGRAPHICAL SCOPE 73
2.3 YEARS CONSIDERED FOR THE STUDY 74
2.4 CURRENCY AND PRICING 74
2.5 DBMR TRIPOD DATA VALIDATION MODEL 75
2.6 MULTIVARIATE MODELLING 78
2.7 PRODUCT TYPE LIFELINE CURVE 78
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 79
2.9 DBMR MARKET POSITION GRID 80
2.10 MARKET TESTING TYPE COVERAGE GRID 82
2.11 VENDOR SHARE ANALYSIS 83
2.12 SECONDARY SOURCES 84
2.13 ASSUMPTIONS 84
3 EXECUTIVE SUMMARY 85
4 PREMIUM INSIGHTS 88
4.1 PESTEL ANALYSIS 91
4.2 PORTYER’S FIVE FORCES 92
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 93
5 INDUSTRY INSIGHTS: 94
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 95
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 95
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 95
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 96
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 97
7 MARKET OVERVIEW 98
7.1 DRIVERS 100
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 100
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 100
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 101
7.2 RESTRAINTS 101
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 101
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 102
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 102
7.3 OPPORTUNITIES 103
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 103
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 103
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 104
7.4 CHALLENGES 106
7.4.1 LACK OF SKILLED PROFESSIONALS 106
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 106
8 GLOBAL RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 107
8.1 OVERVIEW 108
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 111
8.2.1 KITS 112
8.2.2 BUFFER 112
8.2.2.1 SOLUTION 112
8.2.2.2 POWDER 112
8.2.3 STANDARD CONCENTRATES 113
8.2.4 PRECIPITATING REAGENTS 113
8.2.5 RADIOISOTOPES 113
8.2.5.1 BETA EMITTERS 113
8.2.5.1.1 TRITIUM 113
8.2.5.1.2 CARBON-14 114
8.2.5.2 GAMMA EMITTERS 114
8.2.5.2.1 IODINE-125 114
8.2.5.2.2 CHROMIUM-51 114
8.2.5.2.3 COBALT-57 114
8.2.6 ANTIBODY/ANTISERUM 115
8.2.6.1 POLYCLONAL 115
8.2.6.2 MONOCLONAL 115
8.2.7 OTHERS 115
8.3 RADIOIMMUNOASSAY ANALYZER 116
9 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION 117
9.1 OVERVIEW 118
9.2 SCIENTIFIC RESEARCH 121
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
9.2.2 RADIOIMMUNOASSAY ANALYZER 122
9.3 CLINICAL DIAGNOSIS 122
9.3.1 INFECTIOUS DISEASE TESTING 123
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
9.3.1.2 RADIOIMMUNOASSAY ANALYZER 123
9.3.2 ALLERGY TESTING 124
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
9.3.2.2 RADIOIMMUNOASSAY ANALYZER 124
9.3.3 ONCOLOGY TESTING 124
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
9.3.3.2 RADIOIMMUNOASSAY ANALYZER 125
9.3.4 ENDOCRINE TESTING 125
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 125
9.3.4.2 RADIOIMMUNOASSAY ANALYZER 125
9.3.5 TOXICOLOGY TESTING 126
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 126
9.3.5.2 RADIOIMMUNOASSAY ANALYZER 126
9.3.6 AUTOIMMUNE DISEASE TESTING 126
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 127
9.3.6.2 RADIOIMMUNOASSAY ANALYZER 127
9.3.7 OTHER DISEASE TESTING 127
10 GLOBAL RADIOIMMUNOASSAY MARKET, BY END USER 128
10.1 OVERVIEW 129
10.2 HOSPITALS 132
10.3 CLINICAL DIAGNOSTIC LABORATORIES 132
10.4 ACADEMIC AND RESEARCH INSTITUTES 133
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 134
10.6 CONTRACT RESEARCH ORGANISATIONS 134
10.7 OTHERS 135
11 GLOBAL RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 136
11.1 OVERVIEW 137
11.2 DIRECT TENDER 140
11.3 ONLINE SALES 141
11.4 THIRD PARTY DISTRIBUTIONS 142
11.5 OTHERS 143
12 GLOBAL RADIOIMMUNOASSAY MARKET, BY REGION 144
12.1 OVERVIEW 145
12.2 NORTH AMERICA 150
12.2.1 U.S. 162
12.2.2 CANADA 169
12.2.3 MEXICO 176
12.3 EUROPE 183
12.3.1 GERMANY 195
12.3.2 FRANCE 203
12.3.3 U.K. 210
12.3.4 ITALY 217
12.3.5 SPAIN 224
12.3.6 RUSSIA 231
12.3.7 TURKEY 238
12.3.8 NETHERLANDS 245
12.3.9 BELGIUM 252
12.3.10 SWITZERLAND 260
12.3.11 REST OF EUROPE 267
12.4 ASIA-PACIFIC 268
12.4.1 CHINA 280
12.4.2 JAPAN 287
12.4.3 INDIA 294
12.4.4 SOUTH KOREA 302
12.4.5 AUSTRALIA 310
12.4.6 INDONESIA 318
12.4.7 PHILIPPINES 325
12.4.8 THAILAND 333
12.4.9 MALAYSIA 341
12.4.10 SINGAPORE 348
12.4.11 REST OF ASIA-PACIFIC 356
12.5 SOUTH AMERICA 357
12.5.1 BRAZIL 368
12.5.2 ARGENTINA 375
12.5.3 REST OF SOUTH AMERICA 382
12.6 MIDDLE EAST AND AFRICA 383
12.6.1 SOUTH AFRICA 395
12.6.2 SAUDI ARABIA 402
12.6.3 UAE 409
12.6.4 EGYPT 417
12.6.5 ISRAEL 425
12.6.6 REST OF MIDDLE EAST AND AFRICA 433
13 GLOBAL RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 434
13.1 COMPANY SHARE ANALYSIS: GLOBAL 434
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 435
13.3 COMPANY SHARE ANALYSIS: EUROPE 436
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 437
14 SWOT ANALYSIS 438
15 COMPANY PROFILE 439
15.1 PERKINELMER INC. 439
15.1.1 COMPANY SNAPSHOT 439
15.1.2 REVENUE ANALYSIS 439
15.1.3 COMPANY SHARE ANALYSIS 440
15.1.4 PRODUCT PORTFOLIO 440
15.1.4 RECENT DEVELOPMENT 441
15.2 MERCK KGAA 442
15.2.1 COMPANY SNAPSHOT 442
15.2.2 REVENUE ANALYSIS 442
15.2.3 COMPANY SHARE ANALYSIS 443
15.2.4 PRODUCT PORTFOLIO 443
15.2.5 RECENT DEVELOPMENTS 443
15.3 BECKMAN COULTER, INC. 445
15.3.1 COMPANY SNAPSHOT 445
15.3.2 COMPANY SHARE ANALYSIS 445
15.3.3 PRODUCT PORTFOLIO 445
15.3.4 RECENT DEVELOPMENT 446
15.4 ABCAM PLC 447
15.4.1 COMPANY SNAPSHOT 447
15.4.2 REVENUE ANALYSIS 447
15.4.3 COMPANY SHARE ANALYSIS 448
15.4.4 PRODUCT PORTFOLIO 448
15.4.5 RECENT DEVELOPMENT 448
15.5 TECAN TRADING AG 449
15.5.1 COMPANY SNAPSHOT 449
15.5.2 REVENUE ANALYSIS 449
15.5.3 COMPANY SHARE ANALYSIS 450
15.5.4 PRODUCT PORTFOLIO 450
15.5.5 RECENT DEVELOPMENT 451
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 452
15.6.1 COMPANY SNAPSHOT 452
15.6.2 PRODUCT PORTFOLIO 452
15.6.3 RECENT DEVELOPMENTS 452
15.7 DEMEDITEC DIAGNOSTICS GMBH 453
15.7.1 COMPANY SNAPSHOT 453
15.7.2 PRODUCT PORTFOLIO 453
15.7.3 RECENT DEVELOPMENTS 454
15.8 DIASOURCE 455
15.8.1 COMPANY SNAPSHOT 455
15.8.2 PRODUCT PORTFOLIO 455
15.8.3 RECENT DEVELOPMENT 455
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 456
15.9.1 COMPANY SNAPSHOT 456
15.9.2 PRODUCT PORTFOLIO 456
15.9.3 RECENT DEVELOPMENTS 456
15.10 HIDEX OY 458
15.10.1 COMPANY SNAPSHOT 458
15.10.2 PRODUCT PORTFOLIO 458
15.10.3 RECENT DEVELOPMENTS 458
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 459
15.11.1 COMPANY SNAPSHOT 459
15.11.2 PRODUCT PORTFOLIO 459
15.11.3 RECENT DEVELOPMENT 461
15.12 INSTITUTE OF ISOTOPES 462
15.12.1 COMPANY SNAPSHOT 462
15.12.2 PRODUCT PORTFOLIO 462
15.12.3 RECENT DEVELOPMENTS 463
15.13 KAMIYA BIOMEDICAL COMPANY 464
15.13.1 COMPANY SNAPSHOT 464
15.13.2 PRODUCT PORTFOLIO 464
15.13.3 RECENT DEVELOPMENTS 464
15.14 MP BIOMEDICALS 465
15.14.1 COMPANY SNAPSHOT 465
15.14.2 PRODUCT PORTFOLIO 465
15.14.3 RECENT DEVELOPMENTS 466
15.15 MYBIOSOURCE.COM. 467
15.15.1 COMPANY SNAPSHOT 467
15.15.2 PRODUCT PORTFOLIO 467
15.15.3 RECENT DEVELOPMENT 467
16 QUESTIONNAIRE 468
17 RELATED REPORTS 471

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 96
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 101
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 102
TABLE 4 GLOBAL RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 5 GLOBAL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 6 GLOBAL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 7 GLOBAL BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 8 GLOBAL RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 9 GLOBAL BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 10 GLOBAL GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 11 GLOBAL ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 12 GLOBAL RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 13 GLOBAL RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
TABLE 14 GLOBAL SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 15 GLOBAL SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 16 GLOBAL CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 17 GLOBAL CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 18 GLOBAL INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 19 GLOBAL ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 20 GLOBAL ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 21 GLOBAL ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 22 GLOBAL TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 126
TABLE 23 GLOBAL AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 24 GLOBAL RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 131
TABLE 25 GLOBAL HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 132
TABLE 26 GLOBAL CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 133
TABLE 27 GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 133
TABLE 28 GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 134
TABLE 29 GLOBAL CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 30 GLOBAL OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 31 GLOBAL RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
TABLE 32 GLOBAL DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 140
TABLE 33 GLOBAL ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 141
TABLE 34 GLOBAL THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 142
TABLE 35 GLOBAL OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 143
TABLE 36 GLOBAL RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 149
TABLE 37 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 154
TABLE 38 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 39 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 40 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 155
TABLE 41 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 155
TABLE 42 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 43 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 155
TABLE 44 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 155
TABLE 45 NORTH AMERICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 46 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 47 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 156
TABLE 48 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 156
TABLE 49 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 50 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 157
TABLE 51 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 157
TABLE 52 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 157
TABLE 53 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 157
TABLE 54 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 157
TABLE 55 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 158
TABLE 56 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 158
TABLE 57 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
TABLE 58 NORTH AMERICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
TABLE 59 NORTH AMERICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 60 NORTH AMERICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 61 NORTH AMERICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 62 NORTH AMERICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 63 NORTH AMERICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 64 NORTH AMERICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 160
TABLE 65 NORTH AMERICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 66 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 161
TABLE 67 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
TABLE 68 U.S. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 69 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 70 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 162
TABLE 71 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 163
TABLE 72 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 73 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 163
TABLE 74 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 163
TABLE 75 U.S. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 76 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 77 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 164
TABLE 78 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 164
TABLE 79 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 80 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 164
TABLE 81 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 165
TABLE 82 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 165
TABLE 83 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 165
TABLE 84 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 165
TABLE 85 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 165
TABLE 86 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 166
TABLE 87 U.S. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 88 U.S. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
TABLE 89 U.S. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 90 U.S. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 91 U.S. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 92 U.S. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 93 U.S. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
TABLE 94 U.S. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 168
TABLE 95 U.S. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
TABLE 96 U.S. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 168
TABLE 97 U.S. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 168
TABLE 98 CANADA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
TABLE 99 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
TABLE 100 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 169
TABLE 101 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 170
TABLE 102 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
TABLE 103 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 170
TABLE 104 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 170
TABLE 105 CANADA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
TABLE 106 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
TABLE 107 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 171
TABLE 108 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 171
TABLE 109 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
TABLE 110 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 171
TABLE 111 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 172
TABLE 112 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 172
TABLE 113 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 172
TABLE 114 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 172
TABLE 115 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 172
TABLE 116 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 173
TABLE 117 CANADA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 173
TABLE 118 CANADA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 119 CANADA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 173
TABLE 120 CANADA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 121 CANADA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 122 CANADA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 123 CANADA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 124 CANADA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 175
TABLE 125 CANADA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
TABLE 126 CANADA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 175
TABLE 127 CANADA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 175
TABLE 128 MEXICO RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 176
TABLE 129 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 176
TABLE 130 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 176
TABLE 131 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 177
TABLE 132 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
TABLE 133 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 177
TABLE 134 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 177
TABLE 135 MEXICO RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
TABLE 136 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178